AB141439
VO-OHpic trihydrate, PTEN inhibitor
VO-OHpic trihydrate, PTEN inhibitor
Be the first to review this product! Submit a review
|
(1 Publication)
MW 417.22 Da, Purity >98%. Potent, selective and reversible PTEN inhibitor (IC50 = 46 nM). Increases PIP3 levels, phosphorylation of Akt and glucose uptake. Active in vivo.
1 Images
- Chemical Structure
Lab
Chemical Structure - VO-OHpic trihydrate, PTEN inhibitor (AB141439)
2D chemical structure image of ab141439, VO-OHpic trihydrate, PTEN inhibitor
製品の詳細
This product is manufactured by BioVision, an Abcam company and was previously called 1801 VO-OHpic, Trihydrate. 1801-25 is the same size as the 25 mg size of ab141439.
出荷温度及び保存条件
出荷温度
Ambient - Can Ship with Ice
短期保存温度
-20°C
長期保存温度
-20°C
保管に関する情報
Store under desiccating conditions|The product can be stored for up to 12 months
文献 (1)
Recent publications for all applications. Explore the full list and refine your search
Oncotarget 9:24778-24786 PubMed29872505
2018
Expression of P-REX2a is associated with poor prognosis in endometrial malignancies.
Applications
Unspecified application
Species
Unspecified reactive species
Sho Takeshita,Yoriko Yamashita,Kosuke Shiomi,Nako Suzuki,Jun Yoshida,Aya Naiki-Ito,Shugo Suzuki,Shinya Akatsuka,Shinya Toyokuni,Takashi Takahashi,Shoko Mase,Atsushi Arakawa,Mayumi Sugiura-Ogasawara,Satoru Takahashi
Abcam product promise
当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com